Alberto L Gil, MD

Specialty unconfirmed

Federal University of Health Science of Porto Alegre

PI on 1 trial 1 publication

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Retinal macular dystrophy type 2

Clinical trials (1)

NCT00668239

Verify independently

ClinicalTrials.gov PI search for Alberto L Gil, MD
PubMed author search

Other specialists for Retinal macular dystrophy type 2

Peers ranked by clinical-trial PI role, publications, and verification quality.

Kai Zhang, MD
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
Laura Andres-Martin, PhD
New York Stem Cell Foundation Research Institute
Francis WB Sanders, MB BChir PhD FRCOphth
Hywel Dda University Health Board
Karim Hammamji, MD
Centre hospitalier de l'Université de Montréal (CHUM)
Ciro Costagliola, Professor
University of Molise
Ronald Klein, MD, MPH
University of Wisconsin, Madison
Roberto dell'Omo, MD
University of Molise

See all specialists for Retinal macular dystrophy type 2 →

← Back to specialists directory